Filtered By:
Vaccination: Cancer Vaccines
Countries: USA Health
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 518 results found since Jan 2013.
Behavioral and Social Drivers of COVID-19 Vaccination in the United States, August-November 2021
CONCLUSIONS: This nationally representative survey found that COVID-19 vaccine uptake was most strongly associated with greater anticipated regret, risk perception, and confidence in vaccine safety and importance, followed by vaccination requirements and social norms. Interventions that leverage these social and behavioral drivers of vaccination have the potential to increase COVID-19 vaccine uptake and could be considered for other vaccine introductions.PMID:36775756 | DOI:10.1016/j.amepre.2023.01.014
Source: Cancer Control - February 12, 2023 Category: Cancer & Oncology Authors: Kimberly E Bonner Kushagra Vashist Neetu S Abad Jennifer L Kriss Lu Meng James T Lee Elisabeth Wilhelm Peng-Jun Lu Rosalind J Carter Kwanza Boone Brittney Baack Nina B Masters Debora Weiss Carla Black Qian Huang Sitaram Vangala Christina Albertin Peter G Source Type: research
A multivalent polyomavirus vaccine elicits durable neutralizing antibody responses in macaques
In this study, we demonstrate that VLPs representing BKPyV genotypes I, II, and IV, as well as JCPyV genotype 2 produced in insect cells elicit robust antibody titers. In rhesus macaques, all monkeys developed neutralizing antibody titers above a previously proposed protective threshold of 10,000. A second inoculation, administered 19 weeks after priming, boosted titers to a plateau of ≥ 25,000 that was maintained for almost two years. No vaccine-related adverse events were observed in any macaques. A multivalent BK/JC VLP immunogen did not show inferiority compared to the single-genotype VLP immunogens. Considering thes...
Source: Vaccine - February 10, 2023 Category: Allergy & Immunology Authors: Alberto Peretti Diana G Scorpio Wing-Pui Kong Yuk-Ying S Pang Michael P McCarthy Kuishu Ren Moriah Jackson Barney S Graham Christopher B Buck Patrick M McTamney Diana V Pastrana Source Type: research
Up-to-Date Colonoscopy Use in Asian and Hispanic Subgroups in New York City, 2003-2016
CONCLUSIONS: We found significant variation in colonoscopy uptake among Asian and Hispanic subgroups. We also identified numerous demographic, socioeconomic, and health-related predictors of colonoscopy uptake. These findings highlight the importance of examining health disparities through the lens of disaggregated racial/ethnic subgroups and have the potential to inform future public health interventions.PMID:36753456 | DOI:10.1097/MCG.0000000000001835
Source: Clinical Colorectal Cancer - February 8, 2023 Category: Cancer & Oncology Authors: Peter S Liang Rachel Dubner Yuhe Xia Matthew Glenn Kevin Lin Neha Nagpal Sandy Ng Chau Trinh-Shevrin Andrea B Troxel Simona C Kwon Source Type: research
More than cervical cancer: Understanding racial/ethnic disparities in oropharyngeal cancer outcomes among males by HPV status
Conclusions: To decrease incidence rates of late stage OPCa, HPV vaccination and possibly, HPV OPCa screening should be advocated, especially in White males. Further research to explicate possible biologic mechanisms and behaviors or comorbidities contributing to the higher OPCa mortality among Black males is needed.PMID:36696662 | DOI:10.1370/afm.20.s1.2625
Source: Annals of Family Medicine - January 25, 2023 Category: Primary Care Authors: Seiichi Villalona Jeanne Ferrante Satsuki Villalona Antoinette Stroup Source Type: research
An Update on Human Papillomavirus Vaccination in the United States
This article highlights the evidence that the HPV vaccine is a safe and highly effective way to prevent cervical cancer, with the strongest predictor of vaccine uptake being practitioner recommendation.PMID:36649341 | DOI:10.1097/AOG.0000000000005056
Source: Obstetrics and Gynecology - January 17, 2023 Category: OBGYN Authors: Teresa K L Boitano Peter W Ketch Isabel C Scarinci Warner K Huh Source Type: research
Cancer statistics, 2023
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.ABSTRACTEach year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries and mortality data collected by the National Center for Health Statistics. In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Cancer incidence increased for prostate cancer by 3% annually from 2014 through 2019 after two decades of decline, tra...
Source: Clinical Lung Cancer - January 12, 2023 Category: Cancer & Oncology Authors: Rebecca L Siegel Kimberly D Miller Nikita Sandeep Wagle Ahmedin Jemal Source Type: research
COVID-19 SeroHub, an online repository of SARS-CoV-2 seroprevalence studies in the United States
Sci Data. 2022 Nov 26;9(1):727. doi: 10.1038/s41597-022-01830-4.ABSTRACTSeroprevalence studies provide useful information about the proportion of the population either vaccinated against SARS-CoV-2, previously infected with the virus, or both. Numerous studies have been conducted in the United States, but differ substantially by dates of enrollment, target population, geographic location, age distribution, and assays used. This can make it challenging to identify and synthesize available seroprevalence data by geographic region or to compare infection-induced versus combined infection- and vaccination-induced seroprevalenc...
Source: Cancer Control - November 26, 2022 Category: Cancer & Oncology Authors: Neal D Freedman Liliana Brown Lori M Newman Jefferson M Jones Tina J Benoit Francisco Averhoff Xiangning Bu Konuralp Bayrak Anna Lu Brent Coffey Latifa Jackson Stephen J Chanock Anthony R Kerlavage Source Type: research
Clinical Performance and Trends during the First Two Months of Monkeypox Virus PCR Testing at Two United States Reference Labs
J Clin Microbiol. 2022 Nov 21:e0137122. doi: 10.1128/jcm.01371-22. Online ahead of print.ABSTRACTRecently, a sustained human-to-human outbreak of monkeypox virus (MPXV), a member of the Orthopoxvirus genus, which includes the etiologic agent of smallpox, has been documented in multiple nonendemic countries, including the United States. Prior to June 2022, testing in the United States was limited to public health labs and the Centers for Disease Control and Prevention. Following recognition of the scope of the outbreak, testing for MPXV has expanded into clinical laboratories. Here, we examine epidemiological characteristic...
Source: Cancer Control - November 21, 2022 Category: Cancer & Oncology Authors: Nicole A P Lieberman Patrick C Mathias Benjamin T Bradley Alexander L Greninger Source Type: research
